by Adam | Mar 24, 2020 | News
March 24, 2020 Niel, Belgium: eTheRNA Immunotherapies nv (‘eTheRNA’ or ‘The Company’), a clinical-stage company developing vaccines and immunotherapies from its proprietary mRNA TriMix platform, today announced that a consortium has been formed with North American and...
by Adam | Mar 20, 2020 | News
Providence-based EpiVax developing 2 coronavirus vaccines, needs more funding by: Sarah Doiron, Logan Wilber Posted: Mar 19, 2020 / 06:00 PM EDT / Updated: Mar 19, 2020 / 06:33 PM EDT Find the full story here. PROVIDENCE, R.I. (WPRI) ─ As the country races to stem the...
by Adam | Mar 20, 2020 | News
Providence biotech company working to create coronavirus vaccine by TAMARA SACHARCZYK, NBC 10 NEWS Wednesday, March 18th 2020 Find the full story here EpiVax in Providence. (WJAR) A team of local scientists are on the front lines of a global pandemic as they race...
by Adam | Mar 4, 2020 | News
March 04, 2020 09:00 ETÂ |Â Source:Â Generex Biotechnology Corporation MIRAMAR, Fla., March 04, 2020 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (https://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the...
by Adam | Mar 4, 2020 | News
PROVIDENCE, R.I., Mar. 4, 2020 – EpiVax Inc., a Rhode Island company, announces a collaboration to develop a novel coronavirus SARS-CoV-2 (COVID-19) vaccine with University of Georgia (UGA, Athens GA) vaccine expert Ted Ross (Director, Center for Vaccines and...
